Efficacy and safety of TACE-HAIC combined with tyrosine kinase inhibitors and immune checkpoint inhibitors for the patients with BCLC-defined stage B-C HCC

BackgroundTo evaluate the therapeutic efficacy and safety profile of combining transarterial chemoembolization (TACE) with hepatic arterial infusion chemotherapy (HAIC) combined with tyrosine kinase inhibitors (TKIs) and immune checkpoint inhibitors (ICIs) in patients with hepatocellular carcinoma (...

Descripció completa

Dades bibliogràfiques

Autors principals:	Bowen Liu, Linan Yin, Yuxin Chen, Xunbo Hou, Yingchen Li, Xuesong Liu, Ruibao Liu
Format:	Artigo
Idioma:	Inglês
Publicat:	Frontiers Media S.A. 2025-07-01
Col·lecció:	Frontiers in Oncology
Matèries:	hepatocellular carcinoma transarterial chemoembolization hepatic arterial infusion chemotherapy tyrosine kinase inhibitors immune checkpoint inhibitors propensity score matching
Accés en línia:	https://www.frontiersin.org/articles/10.3389/fonc.2025.1615506/full
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!